Who Is Funding the Science That's Too Early for Venture Capital?
April 22, 2026
Joslin Diabetes Center
#52 in Institutes and Centers
52Institution Overview
Overall
Ranking
52
48
Rank in
Research Capabilities
46
Rank in
Entrepreneurial Readiness
37
Rank in
Market Translation
Boston, MA
Joslin Diabetes Center ranks 52nd among the 60 biomedical institutes evaluated in the Cure Innovation Index, and is based in Boston, Massachusetts. Dedicated entirely to diabetes research and clinical care, the center's strongest domain performance comes in market translation, where it outpaces its standing in both research capabilities and entrepreneurial readiness. Faculty-led clinical trials anchor its translational work, connecting laboratory science to patient-facing investigation. As a specialty institute with a single-disease focus, Joslin represents a different model from the multi-mission centers that predominate in U.S. biomedical research.
Ranking Metrics
Research Capabilities
Joslin Diabetes Center ranked below average for Research Capabilities, a measure of the foundational infrastructure and resources that enable an institution to conduct high-quality, innovative science. Out of the factors in this category, Joslin Diabetes Center fared best in Funding Support.
Learn MoreEntrepreneurial Readiness
Joslin Diabetes Center ranked below average for Entrepreneurial Readiness, a measure of whether the institution has built a supportive ecosystem for entrepreneurship and whether faculty are engaged in and incentivized toward commercial activity. Out of the factors in this category, Joslin Diabetes Center fared best in Ecosystem Support.
Learn MoreMarket Translation
Joslin Diabetes Center ranked below average for Market Translation, a measure of how effectively a research institution moves scientific discovery out of the lab and into real-world clinical and commercial applications. Out of the factors in this category, Joslin Diabetes Center fared best in TTO Efficiency.
Learn More
Cure Innovation Index Methodology
From a pool of more than 6,000 institutions, the top 303 were ranked using two dozen indicators — from scientific foundation and lab infrastructure to patents, products, and partnerships — drawn from more than a dozen federal and commercial databases, an original audit of all institutions, and surveys of more than 3,300+ scientists, industry leaders, and biomedical experts.
Insights From the Cure Innovation Index
Explore by Category
Innovation isn't a single moment — it's an entire ecosystem. The Index evaluates institutions across two dozen indicators, grouped in three core domains that reveal the full picture of what it takes to turn groundbreaking science into real-world impact.
